Physician profile
Benjamin Devries
NPI 1164738159
$10,293.25
in general payments reported to CMS, 2019-2025
52 companies · $1,431 in 2025
The $1,431 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2020: $1,213 · 2021: $2,094 · 2022: $1,813 · 2023: $1,761 · 2024: $1,489 · 2025: $1,431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,680.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,434.69 | 2019-2025 | Mounjaro, Emgality, Reyvow |
| Abbvie INC. | $914.70 | 2021-2025 | Qulipta, Ubrelvy, Vraylar |
| Novo Nordisk INC | $836.85 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $742.98 | 2019-2025 | |
| Glaxosmithkline, LLC. | $708.64 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals Lp | $497.45 | 2019-2025 | Airsupra, Farxiga, Fasenra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $392.04 | 2020-2025 | Xifaxan |
| Amgen INC. | $365.60 | 2019-2025 | Repatha, Otezla, Otezla |
| Amarin Pharma, INC. | $348.88 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $323.40 | 2019-2025 | Jardiance |
| Abbott Laboratories | $318.44 | 2021-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Biohaven Pharmaceuticals, INC. | $276.67 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $263.84 | 2020-2023 | Xarelto |
| Tersera Therapeutics LLC | $253.74 | 2022-2025 | Quzyttir |
| Mylan Specialty L.P. | $211.88 | 2020-2023 | Yupelri |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company Ltd. | $189.15 | 2022 | |
| Novartis Pharmaceuticals Corporation | $184.04 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $180.61 | 2019-2025 | Hyqvia |
| Bayer Healthcare Pharmaceuticals INC. | $166.94 | 2023-2025 | |
| Lundbeck LLC | $146.74 | 2021-2025 | Vyepti, Rexulti |
| Esperion Therapeutics, INC. | $120.24 | 2020-2025 | Nexletol |
| Astellas Pharma US INC | $118.55 | 2023-2025 | Veozah, Myrbetriq |
| Allergan, INC. | $113.71 | 2020 | |
| Sanofi-Aventis U.S. LLC | $100.98 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $95.50 | 2019-2021 | |
| Exact Sciences Corporation | $90.94 | 2023-2025 | Cologuard Collection Kit |
| Csl Behring | $74.10 | 2022-2024 | Hizentra |
| Eisai INC. | $73.93 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $67.45 | 2024 | Voquezna |
| Lucid Diagnostics INC. | $56.39 | 2022-2023 | |
| Boston Scientific Corporation | $54.32 | 2024-2025 | General - Pain Management, General - Atherectomy, Watchman Access System |
| Merck Sharp & Dohme LLC | $49.74 | 2019-2023 | Verquvo, Januvia, Belsomra |
| Kowa Pharmaceuticals America, INC. | $48.55 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $43.71 | 2020-2021 | |
| Dexcom, INC. | $42.20 | 2024-2025 | Dexcom G6 Transmitter |
| Upsher-Smith Laboratories LLC | $41.95 | 2020 | |
| Renalytix Ai, INC. | $38.62 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Idorsia Pharmaceuticals US INC | $33.64 | 2022-2023 | Quviviq |
| Blueprint Medicines Corporation | $29.44 | 2025 | Ayvakit |
| Tonix Medicines, INC. | $24.70 | 2025 | Tonmya |
| Paratek Pharmaceuticals, INC. | $24.02 | 2021 | |
| Axsome Therapeutics, INC. | $23.35 | 2025 | Symbravo |
| Shield Therapeutics INC | $22.77 | 2023 | Accrufer |
| Aimmune Therapeutics, INC. | $21.77 | 2025 | Zenpep |
| Inogen, INC. | $21.53 | 2022 | |
| Supernus Pharmaceuticals, INC. | $17.48 | 2021 | |
| Currax Pharmaceuticals LLC | $16.62 | 2022 | |
| Melinta Therapeutics, LLC | $15.68 | 2019 | |
| Inari Medical, INC. | $14.95 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Genentech USA, INC. | $13.57 | 2020 | |
| Impel Pharmaceuticals INC. | $13.19 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Devries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.